Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - ATHERSYS, INC / NEWd328702dex321.htm
EX-31.2 - EXHIBIT 31.2 - ATHERSYS, INC / NEWd328702dex312.htm
EX-31.1 - EXHIBIT 31.1 - ATHERSYS, INC / NEWd328702dex311.htm
EX-23.1 - EXHIBIT 23.1 - ATHERSYS, INC / NEWd328702dex231.htm
EX-21.1 - EXHIBIT 21.1 - ATHERSYS, INC / NEWd328702dex211.htm
EX-10.42 - EXHIBIT 10.42 - ATHERSYS, INC / NEWd328702dex1042.htm
10-K - FORM 10-K - ATHERSYS, INC / NEWd328702d10k.htm

EXHIBIT 24.1

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned officers and directors of Athersys, Inc., a Delaware corporation, hereby constitutes and appoints of Gil Van Bokkelen, William Lehmann, Jr., and Laura K. Campbell, and each of them, as his true and lawful attorney or attorneys-in-fact, with full power of substitution and revocation, for each of the undersigned and in the name, place, and stead of each of the undersigned, to sign on behalf of each of the undersigned an Annual Report on Form 10-K for the fiscal year ended December 31, 2016 pursuant to Section 13 of the Securities Exchange Act of 1934 and to sign any and all amendments to such Annual Report, and to file the same, with all exhibits thereto, and other documents in connection therewith including, without limitation, a Form 12b-25 with the Securities and Exchange Commission, granting to said attorney or attorneys-in-fact, and each of them, full power and authority to do so and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorney or attorneys-in-fact or any of them or their substitute or substitutes may lawfully do or cause to be done by virtue thereof.

This power of attorney may be executed in multiple counterparts, each of which shall be deemed an original with respect to the person executing it.

IN WITNESS WHEREOF, the undersigned have hereunto set their hands as of the 11th day of January, 2017.

 

Signature

  

Title

/s/ Gil Van Bokkelen

Gil Van Bokkelen

   Chief Executive Officer and Chairman of the Board of Directors

/s/ Laura K. Campbell

Laura K. Campbell

   Senior Vice President of Finance

/s/ John J. Harrington

John J. Harrington

   Executive Vice President, Chief Scientific Officer and Director

/s/ Lorin J. Randall

Lorin J. Randall

   Director

/s/ Jack L. Wyszomierski

Jack L. Wyszomierski

   Director

/s/ Kenneth H. Traub

Kenneth H. Traub

   Director

/s/ Ismail Kola

Ismail Kola

   Director

/s/ Lee E. Babiss

Lee E. Babiss

   Director